FDA Clears Selux Rapid Antibiotic Susceptibility Testing Platform
Selux received 510(k) clearance for its a rapid antibiotic susceptibility testing platform that offers targeted therapeutic results quickly.
Read MorePosted by Andy Lundin | Jan 19, 2023 | Disease States |
Selux received 510(k) clearance for its a rapid antibiotic susceptibility testing platform that offers targeted therapeutic results quickly.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Diagnostic Technologies |
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Colorectal |
Helio Genomics unveiled positive finds of its multimodal epigenetic sequencing assay (MESA) for colon cancer detection.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
NuraLogix unveiled a platform that performs continuous health and vital sign measurements while on a video telemedicine call.
Read More